---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-101952"
form_type: "8-K"
ticker: "CTSO"
cik: "0001175151"
company_name: "Cytosorbents Corp"
filed_at: "2023-09-19T23:59:59+00:00"
generated_at: "2026-06-10T13:03:40.297174+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# CytoSorbents appoints Kathleen P. Bloch as full-time CFO with new employment agreement

## Summary
- Bloch returns as CFO effective Sept 2, 2023, replacing former CFO D'Amico after his departure following an investigation.
- Annual base salary of $425,000; eligible for cash bonus up to 45% of base salary at CEO's discretion.
- Equity award: 45,000 RSUs (25k vest immediately, 10k on each of first two anniversaries) and 30,000 options (same vesting schedule).
- Employment agreement runs through Dec 31, 2025 unless terminated earlier.

## SEC filing metadata
- accession: 0001104659-23-101952
- form_type: 8-K
- ticker: CTSO
- cik: 0001175151
- company_name: Cytosorbents Corp
- filed_at: 2023-09-19T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1175151/000110465923101952/0001104659-23-101952-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1175151/000110465923101952/tm2326325d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-101952
- JSON: https://secwatch.observer/filing/0001104659-23-101952.json
- Plain text: https://secwatch.observer/filing/0001104659-23-101952.txt

## Key facts
- Executive change
  Kathleen P. Bloch was appointed as Chief Financial Officer at Cytosorbents Corp.
  - Action: appointed
  - Role: Chief Financial Officer
  source text: Ms. Bloch will continue to serve as the Company’s Chief Financial Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1175151/000110465923101952/0001104659-23-101952-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.